Michael John Foulis

Title: Michael John Foulis: Innovator in Anti-Thrombotic Compounds

Introduction

Michael John Foulis is a notable inventor based in Bracknell, GB. He has made significant contributions to the field of chemistry, particularly in the development of anti-thrombotic agents. With a total of 5 patents to his name, Foulis has demonstrated a commitment to innovation and research.

Latest Patents

Foulis's latest patents include groundbreaking work on cyclopentone propanoic acid compounds. These compounds are derivatives of the formula where R¹ is a C₁-8 alkyl group, optionally substituted by hydroxyl or --COOH, and R² is hydrogen or a protecting group. They are recognized for their utility as anti-thrombotic agents. Another significant patent involves 3-substituted propanoic acid derivatives. This invention provides 3-(2-formyl-3-hydroxy-5-oxocyclopent-1-enyl)-propanoic acid and its derivatives, which exhibit anti-thrombotic activity coupled with low toxicity. The method for preparing these compounds involves oxidative cleavage of a specific precursor compound.

Career Highlights

Foulis is currently associated with Lilly Industries, Inc., where he continues to advance his research in medicinal chemistry. His work has been instrumental in developing new therapeutic agents that can potentially improve patient outcomes in thrombotic conditions.

Collaborations

Throughout his career, Foulis has collaborated with esteemed colleagues such as William Dawson and Norman James Gutteridge. These partnerships have fostered a collaborative environment that enhances innovation and research productivity.

Conclusion

Michael John Foulis is a distinguished inventor whose work in anti-thrombotic compounds has made a significant impact in the field of chemistry. His innovative patents and collaborations reflect his dedication to advancing medical science.